Advances in metal-based probes for MR molecular imaging applications

Current Medicinal Chemistry

Volumn 17, Issue 31, 2010, Pages 3684-3700

  Terreno, E ^a   Dastru W ^a   Castelli, D Delli ^a   Gianolio, E ^a   Crich, S Geninatti ^a   Longo, D ^a   Aime, S ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

CEST; Contrast agents; Iron oxides; Lanthanide; Liposomes; Molecular imaging; MRI

Indexed keywords

COBALT; CONTRAST MEDIUM; FERRISTENE; FERUCARBOTRAN; FERUMOXSIL; GADOLINIUM; IRON OXIDE; LANTHANIDE; MANGAFODIPIR; MANGANESE; METAL; NICKEL; SUPERPARAMAGNETIC IRON OXIDE;

ANISOTROPY; ARTICLE; COMPLEX FORMATION; DIAGNOSTIC IMAGING; DIPOLE; HUMAN; MAGNETISM; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIA; GADOLINIUM; HUMANS; IRON; LANTHANOID SERIES ELEMENTS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MANGANESE; METALS; MOLECULAR IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 78449233292     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710793213823     Document Type: Article

References (136)

1. Hoult, D.I.; Lauterbur, P.C. The sensitivity of the zeumatographic experiment involving human samples. J. Magn. Reson., 1979, 34, 425-433.
2. ST use of Gddtpa dimeglumine in man. Physiol. Chem. Phys. Med. NMR, 1984, 16, 157-165.
3. Lauffer, R.B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem. Rev. 1987, 87, 901-927.
4. Aime, S.; Delli Castelli, D.; Geninatti Crich, S.; Gianolio, E.; Terreno, E. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc. Chem. Res., 2009, 42, 822-831.
5. Caravan, P. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Acc. Chem. Res., 2009, 42, 851-862.
6. Werner, E.J.; Datta, A.; Jocher, C.J.; Raymond, K.N. Highrelaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Angew. Chemie Int. Ed., 2008, 47, 8568-8580.
7. Hermann, P.; Kotek, J.; Kubicek, V.; Lukes, I. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. Dalton Trans., 2008, 23, 3027-3047.
8. Caravan, P.; Ellison, J.J.; McMurry, T.J.; Lauffer, R.B. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev., 1999, 99, 2293.
9. Geraldes, C.F.G.C.; Laurent, S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol. Imaging, 2009, 4, 1-23.
10. Aime, S.; Geninatti Crich, S.; Gianolio, E.; Giovenzana, G.B.; Tei, L.; Terreno, E. High sensitivity lanthanide(III) based probes for MR-medical imaging Coord. Chem. Rev. 2006, 250, 1562-1579.
11. Aime, S.; Botta, M.; Terreno, E. Gd(III)-based contrast agents for MRI. Adv. Inorg. Chem., 2005, 57, 173-237.
12. Weissleder, R.; Mahmood, U. Molecular imaging. Radiology, 2001, 219, 316-333.
13. Corot, C.; Robert, P.; Idée, J.M.; Port, M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev., 2006, 58, 1471-1504.
14. Ward, K.M.; Aletras, A.H.; Balaban, R.S. J. Magn. Reson. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST) 2000, 143, 79-87.
15. Bloembergen, N.; Morgan, L. O. Proton relaxation times in paramagentic ions. J. Chem. Phys., 1961, 34, 842-850.
16. Aime, S.; Barge, A.; Botta, M.; Casnati, A.; Fragai, M.; Luchinat, C.; Ungaro, R. A calix[4]arene Gd-III complex endowed with high stability, relaxivity, and binding affinity to serum albumin. Angew. Chemie Int. Ed., 2001, 40, 4737.
17. Avedano, S.; Tei, L.; Lombardi, A.; Giovenzana, G.B.; Aime, S.; Longo, D.; Botta, M. Maximizing the relaxivity of HSA-bound gadolinium complexes by simultaneous optimization of rotation and water exchange. Chem. Commun., 2007, 4726-4728.
18. Zhang, Z.; Greenfield, M.T.; Spiller, M.; McMurry, T.J.; Lauffer, R.B.; Caravan, P. Multilocus binding increases the relaxivity of protein-bound MRI contrast agents. Angew. Chem. Int. Ed., 2005, 44, 6766-6769.
19. Port, M.; Meyer, D.; Bonnemain, B.; Corot, C.; Schaefer, M.; Rousseaux, O.; Simonot, C.; Bourrinet, P.; Benderbous, S.; Dencausse, A.; Devoldere, L. P760 and P775: MRI contrast agents characterized by new pharmacokinetic properties. Magn. Reson. Mater. Phy., 1999, 8, 172-176.
20. Port, M.; Corot, C.; Rousseaux, O.; Raynal, I.; Devoldere, L.; Idée, J.M.; Dencausse, A.; Le Greneur, S.; Simonot, C.; Meyer, D. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results. Magn. Reson. Mater. Phy., 2001, 12, 121-127.
21. Fulton, D.A.; O'Halloran, M.; Parker, D.; Senanayake, K.; Botta, M.; Aime, S. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates. Chem. Commun., 2005, 474-476.
22. Jacques, V.; Desreux, J.F. New classes of MRI contrast agents. Top. Curr. Chem., 2002, 221, 123-164.
23. Livramento, J.B.; Toth, E.; Sour, A.; Borel, A.; Merbach, A.E.; Ruloff, R. High relaxivity confined to a small molecular space: A metallostar-based, potential MRI contrast agent. Angew. Chem. Int. Ed., 2005, 44, 1480-1484.
24. Laus, S.; Ruloff, R.; Toth, E.; Merbach, A.E. Gd-III complexes with fast water exchange and high thermodynamic stability: Potential building blocks for high-relaxivity MRI contrast agents. Chem. Eur. J., 2003, 9, 3555-3566.
25. Kotek, J.; Lebduskova, P.; Hermann, P.; Vander Elst, L.; Muller, R.N.; Geraldes, C.F.G.C.; Maschmeyer, T.; Lukes, I.; Peters, J.A. Lanthanide(III) complexes of novel mixed carboxylic-phosphorus acid derivatives of diethylenetriamine: A step towards more efficient MRI contrast agents. Chem. Eur. J., 2003, 9, 5899-5915.
26. Aime, S.; Gianolio, E.; Longo, D.; Pagliarin, R.; Lovazzano, C.; Sisti, M. New insights for pursuing high relaxivity MRI agents from modelling the binding interaction of Gd-III chelates to HSA. ChemBioChem, 2005, 6, 818.
27. Tei, L.; Botta, M.; Lovazzano, C.; Barge, A.; Milone, L.; Aime, S. H-1 and O-17 NMR relaxometric study in aqueous solution of Gd(III) complexes of EGTA-like derivatives bearing methylenephosphonic groups. Magn. Reson. Chem., 2008, 46, S86-S93.
28. Jaszberenyi, Z.; Sour, A.; Toth, E.; Benmelouka, M.; Merbach, A.E. Fine-tuning water exchange on Gd-III poly(amino carboxylates) by modulation of steric crowding. Dalton Trans., 2005, 2713-2719.
29. Tei, L.; Gugliotta, G.; Baranyai, Z.; Botta, M. A new bifunctional Gd(III) complex of enhanced efficacy for MR-molecular imaging applications. Dalton Trans., 2009, 9712-9714.
30. Aime, S.; Chiaussa, M.; Digilio, G.; Gianolio, E.; Terreno, E. Contrast agents for magnetic resonance angiographic applications: H-1 and O-17 NMR relaxometric investigations on two gadolinium(III) DTPA-like chelates endowed with high binding affinity to human serum albumin. J. Biol. Inorg. Chem., 1999, 4, 766-774.
31. Aime, S.; Botta, M.; Garino, E.; Geninatti Crich, S.; Giovenzana, G.B.; Pagliarin, R.; Palmisano, G.; Sisti, M. Non-covalent conjugates between cationic polyamino acids and Gd-III chelates: A route for seeking accumulation of MRI-contrast agents at tumor targeting sites. Chem. Eur. J., 2000, 6, 2609-2617.
32. Zech, S.G.; Eldredge, H.B.; Lowe, M.P.; Caravan, P. Protein binding to lanthanide(III) complexes can reduce the water exchange rate at the lanthanide. Inorg. Chem., 2007, 46, 3576-3584.
33. Aime, S.; Botta, M.; Geninatti Crich, S.; Giovenzana, G.B.; Jommi, G.; Pagliarin, R.; Sisti, M. Synthesis and NMR studies of three pyridine-containing triaza macrocyclic triacetate ligands and their complexes with lanthanide ions. Inorg. Chem., 1997, 36, 2992-3000.
34. Port, M.; Raynal, I.; Vander Elst, L.; Muller, R.N.; Dioury, F.; Ferroud, C.; Guy, A. Impact of rigidification on relaxometric properties of a tricyclic tetraazatriacetic gadolinium chelate. Contr. Media Mol. Imaging, 2006, 1, 121-126.
35. Tircso, G.; Benyo, E.T.; Suh, E.H.; Jurek, P., Kiefer, G.E., Sherry, A.D.; Kovacs, Z. (S)-5-(p-Nitrobenzyl)-PCTA, a Promising Bifunctional Ligand with Advantageous Metal Ion Complexation Kinetics. Bioconjugate Chem., 2009, 20, 565-575.
36. Aime, S.; Calabi, L.; Cavallotti, C.; Gianolio, E.; Giovenzana, G.B.; Losi, P.; Maiocchi, A.; Palmisano, G.; Sisti, M [GdAAZTA](-): A new structural entry for an improved generation of MRI contrast agents. Inorg. Chem., 2004, 43, 7588-7590.
37. Elemento, E.M.; Parker, D.; Aime, S.; Gianolio, E.; Lattuada, L. Variation of water exchange dynamics with ligand structure and stereochemistry in lanthanide complexes based on 1,4-diazepine derivatives. Org. Biomol. Chem., 2009, 7, 1120-1131.
38. Gugliotta, G.; Botta, M.; Giovenzana, G.B.; Tei, L. Fast and easy access to efficient bifunctional chelators for MRI applications. Bioorg. Med. Chem. Lett., 2009, 19, 3442-3444.
39. Hajela, S.; Botta, M.; Giraudo, S.; Xu, J.D.; Raymond, K.N.; Aime, S. A tris-hydroxymethyl-substituted derivative of Gd-TREN-Me3,2-HOPO: An MRI relaxation agent with improved efficiency. J. Am. Chem. Soc., 2000, 122, 11228-11229.
40. Thompson, M.K.; Botta, M.; Nicolle, G.; Helm, L.; Aime, S.; Merbach, A.E.; Raymond, K.N. A highly stable gadolinium complex with a fast, associative mechanism of water exchange. J. Am. Chem. Soc., 2003, 125, 14274-14275.
41. Thompson, M.K.; Misselwitz, B.; Tso, L.S.; Doble, D.M.J.; Schmitt-Willich, H.; Raymond, K.N. In vivo evaluation of gadolinium hydroxypyridonate chelates: Initial experience as contrast media in magnetic resonance imaging. J. Med. Chem., 2005, 48, 3874-3878.
42. Datta, A.; Raymond, K.N. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents. Acc. Chem. Res., 2009, 42, 938-947.
43. Aime, S.; Botta, M.; Geninatti Crich, S.; Giovenzana, G.B.; Pagliarin, R.; Piccinini, M.; Sisti, M.; Terreno, E. Towards MRI contrast agents of improved efficacy. NMR relaxometric investigations of the binding interaction to HSA of a novel heptadentate macrocyclic triphosphonate Gd(III)-complex. J. Biol. Inorg. Chem., 1997, 2, 470-479.
44. Gianolio, E.; Giovenzana, G.B.; Longo, D.; Longo, I.; Menegotto, I.; Aime, S. Relaxometric and modelling studies of the binding of a lipophilic Gd-AAZTA complex to fatted and defatted human serum albumin. Chem. Eur. J., 2007, 13, 5785-5797.
45. Geninatti Crich, S.; Lanzardo, S.; Alberti, D.; Belfiore, S.; Ciampa, A.; Giovenzana, G.B.; Lovazzano, C.; Pagliarin, R.; Aime, S. Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles. Neoplasia, 2007, 9, 1046-1056.
46. Pierre, V. C.; Botta, M.; Raymond, K. N. Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength. J. Am. Chem. Soc., 2005, 127, 504-505.
47. Datta, A.; Hooker, J. M.; Botta, M.; Francis, M. B.; Aime, S.; Raymond, K. N. High relaxivity gadolinium hydroxypyridonateviral capsid conjugates: Nanosized MRI contrast agents. J. Am. Chem. Soc., 2008, 130, 2546-2552.
48. Longmire, M.; Choyke, P.L.; Kobayashi, H. Dendrimer-based contrast agents for molecular imaging. Curr. Top. Med. Chem., 2008, 8, 1180-1186.
49. Caravan, P. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Acc. Chem. Res., 2009, 42, 851-862.
50. Accardo, A.; Tesauro, D.; Aloj, L.; Pedone, C.; Morelli, G. Supramolecular aggregates containing lipophilic Gd(III) complexes as contrast agents in MRI. Coord. Chem. Rev., 2009, 253, 2193-2213.
51. Mulder, W.J.M.; Strijkers, G.J.; Van Tilborg, G.A.F.; Cormode, D.P.; Fayad, Z.A.; Nicolay, K. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc. Chem. Res., 2009, 42, 904-914.
52. Lanza, G.M.; Winter, P.M.; Neubauer, A.M.; Caruthers, S.D.; Hockett, F.D.; Wickline, S.A. H-1/F-19 magnetic resonance molecular imaging with perfluorocarbon nanoparticles. Curr. Top. Dev. Biol., 2005, 70, 57-76.
53. Sitharaman, B.; Wilson, L.J. Gadofullerenes and gadonanotubes: A new paradigm for high-performance magnetic resonance imaging contrast agent probes. J. Biomed. Nanotechnol., 2007, 3, 342-352.
54. Na, H.B.; Hyeon, T. Nanostructured T1 MRI contrast agents. J. Mater. Chem., 2009, 19, 6267-6273.
55. Aime, S.; Frullano, L.; Geninatti Crich, S. Compartmentalization of a gadolinium complex in the apoferritin cavity: A route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew. Chem. Int. Ed., 2002, 41, 1017.
56. Vasalatiy, O.; Zhao, P.; Zhang, S.; Aime, S.; Sherry, A.D. Catalytic effects of apoferritin interior surface residues on water proton exchange in lanthanide complexes. Contrast Media Mol. Imaging, 2006, 1, 10.
57. Delli Castelli, D.; Gianolio, E.; Geninatti Crich, S.; Terreno, E.; Aime, S. Metal containing nanosized systems for MR-Molecular Imaging applications. Coord. Chem. Rev., 2008, 252, 2424-2443.
58. Geninatti Crich, S.; Bussolati, B.; Tei, L.; Grange, C.; Esposito, G.; Lanzardo, S.; Camussi, G.; Aime, S. Magnetic Resonance Visualization of Tumor Angiogenesis by Targeting Neural Cell Adhesion Molecules with the Highly Sensitive Gadolinium-Loaded Apoferritin Probe. Cancer Res., 2006, 66, 9196-9201.
59. Morawski, A.M.; Winter, P.M.; Crowder, K.C.; Caruthers, S.D.; Fuhrhop, R.W.; Scott, M.J.; Robertson, J.D.; Abendschein, D.R.; Lanza, G.M.; Wickline, S.A. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn. Reson. Med. 2004, 51, 480-486.
60. Viglianti, B.L.; Abraham, S.A.; Michelich, C.R.; Yarmolenko, P.S.; MacFall, J.R.; Bally, M.B.; Dewhirst, M.W. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery. Magn. Reson. Med. 2004, 51, 1153-1162.
61. de Smet, M.; Langereis, S.; den Bosch, S.V.; Grüll, H. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance. J. Control. Release., 2010, 143, 120-127.
62. Grange, C.; Geninatti-Crich, S.; Esposito, G.; Alberti, D.; Tei, L.; Bussolati, B.; Aime, S.; Camussi, G. Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced kaposi's sarcoma. Cancer Res., 2010, 70, 2180-2190.
63. Terreno, E.; Sanino, A.; Carrera, C.; Delli Castelli, D.; Giovenzana, G.B.; Lombardi, A.; Mazzon, R.; Milone, L.; Visigalli, M.; Aime, S. Determination of water permeability of paramagnetic liposomes of interest in MRI field. J. Inorg. Biochem., 2008, 102, 1112-1119.
64. Lindner, L.H.; Reinl, H.M.; Schlemmer, M.; Stahl, R.; Peller, M. Paramagnetic thermosensitive liposomes for MR-thermometry. Int. J. Hyperthermia, 2005, 21, 575-588.
65. Brandwijk, R.J.; Mulder, W.J.; Nicolay, K.; Mayo, K.H.; Thijssen, V.L.; Griffioen, A.W. Anginex-conjugated liposomes for targeting of angiogenic endothelial cells. Bioconjug. Chem., 2007 18, 785-790.
66. Louie, A. Y.; Huber, M. M.; Ahrens, E. T.; Rothbacher, U.; Moats, R.; Jacobs, R. E.; Fraser, S. E.; Meade, T. J. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol., 2000, 18, 321-325.
67. Major G.L.; Meade T.J. Bioresponsive, cell-penetrating, and multimeric MR contrast agents. Acc. Chem. Res., 2009, 42, 893-903.
68. Rodriguez, E.; Nilges, M.; Weissleder, R.; Chen, J.W. Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity. J. Am. Chem. Soc., 2010, 132, 168-177.
69. Raghunand, N.; Howison, C.; Sherry, A.D.; Zhang, S.; Gillies, R.J. Renal and systemic pH imaging by contrast-enhanced MRI. Magn. Reson. Med., 2003, 49, 249-257.
70. Garcia-Martin, M.L.; Martinez, G.V.; Raghunand, N.; Sherry, A.D.; Zhang, S.; Gillies, R.J. High resolution pH(e) imaging of rat glioma using pH-dependent relaxivity. Magn. Reson. Med., 2006, 55, 309-315.
71. Aime, S.; Fedeli, F.; Sanino, A.; Terreno, E. A R2/R1 ratiometric procedure for a concentration-independent, pH-responsive, Gd(III)based MRI agent. J. Am. Chem. Soc., 2006, 128, 11326-11327.
72. 1H MRI method. Chem. Commun., 2009, 6044-6046.
73. Broome, D.R. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting. Eur. J. Radiol., 2008, 66, 230-234.
74. Pautler, R.G. In vivo, trans-synaptic tract-tracing utilizing manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed., 2004, 17, 595-601.
75. Adzamli, K.; Dorshow, R.B.; Hynes, M.R.; Nosco, D.L.; Adams, M.D. Characterization of polyethyleneglycol-stabilized, manganese-substituted hydroxylapatite (MnHA-PEG). A potential MR blood pool agent. Acta Radiol Suppl., 1997, 412, 73-78.
76. Mäurer, J.; Strauss, A.; Ebert, W.; Bauer, H.; Felix, R. Contrastenhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results. Melanoma Res., 2000, 10, 40-46.
77. Aime, S.; Botta, M.; Gianolio, E.; Terreno, E. A p(O2)-responsive MRI contrast agent based on the redox switch of manganese(II/III) Porphyrin complexes. Angew. Chem. Int. Ed., 2000, 39, 747-748.
78. Na, H.B.; Lee, J.H.; An, K.; Park, Y.; Park, M.; Lee, I.S.; Nam, D.H.; Kim, S. T.; Kim, S.-H.; Kim, S.-W.; Lim, K.-H.; Kim, K.-S.; Kim, S.-O.; Hyeon, T. Development of a T-1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew. Chem. Int. Ed., 2007, 46, 5397-5401.
79. Gilad, A.A.; Walczak, P.; McMahon, M.T.; Na, H.B.; Lee, J.H.; An, K.; Hyeon, T.; van Zijl, P.C.M.; Bulte, J.W.M. MR tracking of transplanted cells with positive contrast using manganese oxide nanoparticles. Magn. Reson. Med., 2008, 60, 1-7.
80. Shin, J.; Anisur, R. M.; Ko, M. K.; Im, G. H.; Lee, J. H.; Lee, I. S. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew. Chem. Int. Ed., 2009, 48, 321-324.
81. Pan, D.; Senpan, A.; Caruthers, S.D.; Williams, T.A.; Scott, M.J.; Gaffney, P.J.; Wickline, S.A.; Lanza, G.M. Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids. Chem. Commun., 2009, 3234-3236.
82. Ferenc, K.K.; Geninatti Crich, S.; Aime, S. Reduction/dissolution of a -MnOOH nanophase in the ferritin cavity to yield a highly sensitive, biologically compatible magnetic resonance imaging agent. Angew. Chem. Int. Ed., 2010, 49, 612-615.
83. Meldrum, F.C.; Douglas, T.; Levi, S.; Arosio, P.; Mann, S. Reconstitution of manganese oxide cores in horse spleen and recombinant ferritins. J. Inorg. Biochem., 1995, 58, 59-68.
84. Hoener, B.; Engelstad, B.L.; Ramos, E.C.; Macapinlac, H.A.; Price, D.C.; Johnson, T.R.; White, D.L. Comparison of Fe-HBED and FeEHPG as hepatobiliary MR contrast agents. J. Magn. Reson Imaging, 1991, 1, 357-362.
85. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; Muller, RN Magnetic Iron Oxide Nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev., 2008, 108, 2064-2110.
86. Mornet, S.; Vasseur, S.; Grasset, F.; Duguet, E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem., 2004, 14, 2161-2175.
87. Fauconnier, N.; Pons, J.N.; Roger, J.; Bee, A. Thiolation of maghemite nanoparticles by dimercaptosuccinic acid. J. Colloid Interface Sci., 1997, 194, 427-433.
88. Fauconnier, N.; Bee, A.; Roger, J.; Pons, J.N. Synthesis of aqueous magnetic liquids by surface complexation of maghemite nanoparticles. J. Mol. Liq., 1999, 83, 233-242.
89. Sosnovik, D.E.; Nahrendorf, M.; Panizzi, P.; Matsui, T.; Aikawa, E.; Dai, G.P.; Li, L.; Reynolds, F.; Dorn, G.W.; Weissleder, R.; Josephson, L.; Rosenzweig, A. Molecular MRI detects low levels of cardiomyocite apoptosis in a transgenic model of chronic heart failure. Circ. Cardiovasc. Imaging, 2009, 2, 460-475.
90. Sosnovik, D.E.; Nahrendorf, M.; Weissleder, R. Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res. Cardiol., 2008, 103, 122-130.
91. Modo, M.; Hoehn, M.; Bulte, J.W. Cellular MR imaging. Mol. Imaging, 2005, 4, 143-164.
92. Cunningham, C.H.; Arai, T.; Yang, P.C.; McConnell, M.V.; Pauly, J.M.; Conolly, S.M. Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles. Magn. Reson. Med., 2005, 53, 999-1005.
93. Stuber, M.; Gilson, W.D.; Schar, M.; Kedziorek, D.A.; Hofmann, L.V.; Shah, S.; Vonken, E.J.; Bulte, J.W.M.; Kraitchman, D.L. Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-Resonant water suppression (IRON). Magn. Reson. Med., 2007, 58, 1072-1077.
94. Suzuki, Y.; Cunningham, C.H.; Noguchi, K.; Chen, I.Y.; Weissman, I.L.; Yeung, A.C.; Robbins, R.C.; Yang, P.C. In vivo serial evaluation of superparamagnetic iron-oxide labeled stem cells by off-resonance positive contrast. Magn. Reson. Med., 2008, 60, 1269-1275.
95. Senpan, A.; Caruthers, S.; Rhee, I.; Mauro, N.; Pan, D.; Hu, G.; Scott, M.; Fuhrop, R.; Gaffney, P.; Wickline, S.; Lanza, G. Conquering the dark side: colloidal iron oxide nanoparticles ACS Nano 2009, 3, 3917-3926.
96. Sherry, AD. MR imaging and spectroscopy applications of lanthanide complexes with macrocyclic phosphonate and phosphonate ester ligands. J. Alloys Comp., 1997, 249, 153-157.
97. Aime, S.; Botta, M.; Fasano, M.; Terreno, E. Ln(III) chelates for NMR biomedical applications. Chem. Soc. Rev., 1998, 27, 19-29.
98. Aime, S.; Botta, M.; Mainero, V.; Terreno, E. Separation of intraand extracellular lactate NMR signals using a lanthanide shift reagent. Magn. Reson. Med., 2002, 47, 10-13.
99. Frenzel, T.; Toth, K.; Kobler, S.; Raduchel, B.; Bauer, H.; Platzek, J.; Weinmann, H.J. Noninvasive temperature measurement in vivo using a temperature-sensitive lanthanide complex and 1H magnetic resonance spectroscopy. Magn. Reson. Med., 1996, 35, 364-369.
100. Aime, S.; Botta, M.; Fasano, M.; Terreno, E.; Kinchesh, P.; Calabi, L.; Paleari, L. A new ytterbium chelate as contrast agent in CSI and temperature probe in MRS. Magn. Reson. Med., 1996, 35, 648-651.
101. Alan, M. Kenwright, Ilya Kuprov, De Elena Luca, David Parker, Shashi U. Pandya, P. Kanthi Senanayake and David G. Smith. 19F NMR based pH probes: lanthanide(III) complexes with pHsensitive chemical shifts. Chem. Commun., 2008 2514-2516.
102. Chalmers, K.H.; De Luca, E.; Hogg, N.H.M.; Kenwright, A.M.; Kuprov, I.; Parker, D.; Botta, M.; Wilson, J.I.; Blamire, A.M. Design principles and theory of paramagnetic fluorine-labelled lanthanide complexes as probes for F-19 magnetic resonance: A proof-of-concept study. Chem. Eur. J., 2010, 16, 134-148.
103. Zhou, J.; van Zijl, P.C.M. Chemical exchange saturation transfer imaging and spectroscopy. Prog. NMR Spectr. 2006, 48, 109-136.
104. Woods, M.; Woessner, D.E.; Sherry, A.D. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem. Soc. Rev., 2006, 35, 500-511
105. Zhang, S.; Merritt, M.; Woessner, D.E.; Lenkinski, R.E.; Sherry, A.D. PARACEST agents: Modulating MRI contrast via water proton exchange. Acc. Chem. Res., 2003, 36, 783-790.
106. Terreno, E; Delli Castelli D.; Aime S. Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. Contrast Media Mol. Imaging, 2010, in press
107. Zhang, S.; Winter, P.; Wu, K.; Sherry, A.D. A novel europium(III)based MRI contrast agent. J. Am. Chem. Soc., 2001, 123, 1517-1518.
108. Terreno, E.; Delli Castelli, D.; Cravotto, G.; Milone, L.; Aime, S.; Ln(III)-DOTAMGly complexes: a versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for magnetic resonance imaging applications. Invest. Radiol., 2004, 39, 235-243.
109. Aime, S.; Delli Castelli, D.; Terreno, E. Novel pH-reporter MRI contrast agents. Angew. Chem. Int. Ed. Engl., 2002, 41, 4334-4336.
110. Aime S, Delli Castelli D, Fedeli F, Terreno E, A paramagnetic MRI-CEST agent responsive to lactate concentration. J. Am. Chem. Soc. 2002; 124: 9364-9365.
111. Zhang, S.; Trokowski, R.; Sherry, A.D. A paramagnetic CEST agent for imaging glucose by MRI. J. Am. Chem. Soc., 2003, 125, 15288-15289.
112. Liu, G.; Li, Y.; Pagel, M.D. Design and characterization of a new irreversible responsive PARACEST MRI Contrast Agent that detects nitric oxide. Magn. Reson. Med., 2007, 58, 1249-1256.
113. Huang, C.-H.; Morrow, J.R. A PARACEST agent responsive to innerand outer-sphere phosphate ester interactions for MRI applications. J. Am. Chem. Soc., 2009, 131, 4206-4207.
114. Trokowski, R.; Ren, J.; Kalman, F.K.; Sherry, A.D. Selective sensing of zinc ions with a PARACEST contrast agent. Angew. Chem. Int. Ed. Engl., 2005, 44, 6920-6923.
115. Yoo, B.; Raam, M.S.; Rosenblum, R.M.; Pagel, M.D. Enzymeresponsive PARACEST MRI contrast agents: a new biomedical imaging approach for studies of the proteasome. Contrast Media Mol. Imaging, 2007, 2, 189-198.
116. Chauvin, T.; Durand, P.; Bernier, M.; Meudal, H.; Doan, B.T.; Noury, F.; Badet, B.; Beloeil, J.C.; Tóth E. Detection of enzymatic activity by PARACEST MRI: a general approach to target a large variety of enzymes. Angew. Chem. Int. Ed. Engl., 2008, 47, 4370-4372
117. Meser Ali, M.; Yoo, B.; Pagel, M.D. Tracking the Relative In vivo Pharmacokinetics of Nanoparticles with PARACEST MRI. Mol. Pharm., 2009, 6, 1409-1416.
118. Pikkemaat, J.A.; Wegh, R.T.; Lamerichs, R.; van de Molengraaf, R.A.; Langereis, S.; Burdinski, D.; Raymond, A.Y.; Janssen, H.M.; de Waal, B.F.; Willard, N.P.; Meijer, E.W.; Grull, H. Dendritic PARACEST contrast agents for magnetic resonance imaging. Contr. Media Mol. Imaging, 2007, 2, 229-239.
119. Wu, Y.; Zhou, Y.; Ouari, O.; Woods, M.; Zhao, P.; Soesbe, T.D.; Kiefer, G.E.; Sherry, A.D. Polymeric PARACEST Agents for Enhancing MRI contrast sensitivity. J. Am. Chem. Soc., 2008, 130, 13854-13855.
120. Winter, P.M.; Cai, K.; Chen, J.; Adair, C.R.; Kiefer, G.E.; Athey, P.S.; Gaffney, P.J.; Buff, C.E.; Robertson, J.D.; Caruthers, S.D.; Wickline, S.A.; Lanza, G.M. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin. Magn. Reson. Med., 2006, 56, 1384-1388.
121. Aime, S.; Delli Castelli, D.; Terreno, E. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. Angew. Chem. Int. Ed., 2005, 44, 5513-5515.
122. Aime, S.; Geninatti Crich, S.; Gianolio, E.; Giovenzana, G.B.; Tei, L.; Terreno, E. High sensitivity lanthanide(III) based probes for MR-medical imaging. Coord. Chem. Rev., 2006, 250, 1562-1579.
123. Chu, S.C.K.; Xu, Y.; Balschi, J.A.; Springer Jr, C.S. Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples. Use of paramagnetic reagents. Magn. Reson. Med., 1990, 13, 239-262.
124. Kuchel, P.W.; Chapman, B.E.; Bubb, W.A.; Hansen, P.E.; Durrant, C.J.; Hertzberg, M.P. Magnetic susceptibility: Solutions, emulsions, and cells. Concepts Magn. Res. A, 2003, 18A, 56-71.
125. Aime, S.; Delli Castelli, D.; Terreno, E. Lanthanide-loaded paramagnetic liposomes as switchable magnetically oriented nanovesicles. Methods Enzymol., 2009, 464, 193-210.
126. Terreno, E.; Delli Castelli, D.; Milone, L.; Rollet, S.; Stancanello, J.; Violante, E.; Aime, S. First ex-vivo MRI co-localization of two LIPOCEST agents. Contr. Med. Mol. Imaging, 2008, 3, 38-43.
127. Langereis, S.; Keupp, J.; van Velthoven, J.L.J.; de Roos, I.H.C.; Burdinski, D.; Pikkemaat, J.A.; Gruell, H. A Temperature-Sensitive Liposomal 1H CEST and 19F Contrast Agent for MR ImageGuided Drug Delivery. J. Am. Chem. Soc., 2009, 131, 1380-1381.
128. Vinogradov, E.; Zhang, S.; Lubag, A.; Balschi, J.A.; Sherry, A.D.; Lenkinski, R.E. On-resonance low B1 pulses for imaging of the effects of PARACEST agents J. Magn. Reson., 2005, 176, 54-63.
129. Vinogradov, E.; He, H.; Lubag, A.; Balschi, J.A.; Sherry, A.D.; Lenkinski, R.E. Magn. Reson. Med. MRI detection of paramagnetic chemical exchange effects in mice kidneys. In Vivo, 2007, 58, 650-655.
130. Caravan, P.; Toth, E.; Rockenbauer, A.; Merbach, A. E. Nuclear and electronic relaxation of Eu-(aq)(2+): An extremely labile aqua ion. J. Am. Chem. Soc., 1999, 121, 10403-10409.
131. Bertini, I.; Capozzi, F.; Luchinat, C.; Nicastro, G.; Xia, Z. Water proton relaxation for some lanthanide aqua ions in solution. J. Phys. Chem., 1993, 97, 6351-6354.
132. Vander Elst, L.; Roch, A.; Gillis, P.; Laurent, S.; Botteman, F.; Bulte Jeff, W. M.; Muller Robert, N. Dy-DTPA derivatives as relaxation agents for very high field MRI: The beneficial effect of slow water exchange on the transverse relaxivities. Magn. Reson. Med., 2002, 47, 1121-1130.
133. Caravan, P.; Greenfield, M.T.; Bulte, J.W.M. Molecular factors that determine Curie spin relaxation in dysprosium complexes. Magn. Reson. Med., 2001, 46, 917-922.
134. Delli Castelli D.; Terreno, E.; Cabella, C.; Chaabane, L.; Lanzardo, S; Tei, L.; Visigalli, M.; Aime, S. Evidence for in vivo macrophage mediated tumor uptake of paramagnetic/fluorescent liposomes. NMR Biomed., 2009, 22, 1084-1092.
135. Lee, J.-H.; Huh, Y.-M.; Jun, Y-W.; Seo, J-W.; Jang, J-T.; Song, H.T.; Kim, S.; Cho, E.-J.; Yoon, H.-G.; Suh, J.-S.; Cheon, J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med., 2007, 13, 95-99.
136. Jun, Y.-W.; Seo, J.-W.; Cheon, J. Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences. Acc. Chem. Res., 2008, 41, 179-189.